The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The requested identity is verified: human DYNC1H1 (UniProt Q14204) is the 4,644-amino-acid cytoplasmic dynein-1 heavy chain 1, not cytoplasmic dynein-2 or an axonemal dynein. It is the catalytic, microtubule-binding, force-generating backbone of the approximately 1.3–1.4-MDa cytoplasmic dynein-1 complex. Its supplied InterPro annotations—AAA+ ATPase, AAA_9, AAA-lid and dynein-heavy-chain domains—agree with the literature’s six-AAA-module motor ring, linker, stalk and microtubule-binding-domain architecture. No conflicting same-symbol protein was encountered. (rao2024structureandfunction pages 1-2, wong2024genomescalerequirementsfor pages 1-2, dahl2021effectofconditional pages 1-2)
Functionally, DYNC1H1 is an ATP-powered, predominantly microtubule-minus-end-directed molecular motor. It is not a membrane transporter with a small-molecule cargo substrate: ATP is its chemical energy substrate, microtubules are its track, and adaptor-bound organelles, vesicles and macromolecular assemblies are its transported cargo. In cells it drives inward/perinuclear transport and, in axons, retrograde movement toward the neuronal soma. (rao2024structureandfunction pages 1-2, wong2024genomescalerequirementsfor pages 1-2)
| Aspect | Evidence-based annotation | Key evidence/source (author–year and DOI URL) |
|---|---|---|
| Identity | Established: Human DYNC1H1 (UniProt Q14204) encodes the 4,644-aa cytoplasmic dynein-1 heavy chain, the catalytic and force-generating backbone of cytoplasmic dynein-1. This identity is distinct from cytoplasmic dynein-2 and axonemal dyneins. | Dahl et al., 2021, 10.1371/journal.pone.0248354 (dahl2021effectofconditional pages 1-2); Becker et al., 2020, 10.1038/s10038-020-0803-1 (simoes2018cytoskeletonandmolecular pages 86-89) |
| Architecture and domains | Established: The N-terminal tail mediates heavy-chain dimerization and scaffolds accessory subunits. The C-terminal motor contains a ring of six AAA+ domains: AAA1 is the principal ATPase; AAA3 and AAA4 regulate motor activity; AAA2 binds ATP but is not detectably catalytic; AAA5–AAA6 are non-nucleotide-binding structural modules. A linker transmits the power stroke, while an approximately 13-nm coiled-coil stalk from AAA4 terminates in the microtubule-binding domain (MTBD); an AAA5 buttress couples ring conformation to MTBD affinity. This agrees with the supplied AAA+, AAA_9, AAA-lid and DHC annotations. | Rao & Gennerich, 2024, published 11 February 2024, 10.3390/cells13040330 (rao2024structureandfunction pages 1-2) |
| Primary biochemical function | Established: DYNC1H1 is an ATP-dependent mechanochemical motor, not a transporter with a small-molecule substrate. Its chemical substrate is principally ATP at AAA1; ATP hydrolysis is coupled to linker and AAA-ring rearrangements, stalk-coil sliding, cyclic changes in MTBD affinity and mechanical movement/force along microtubules. | Rao & Gennerich, 2024, 10.3390/cells13040330 (rao2024structureandfunction pages 1-2); Dahl et al., 2021, 10.1371/journal.pone.0248354 (dahl2021effectofconditional pages 1-2) |
| Complex composition | Established: Cytoplasmic dynein-1 is an approximately 1.3–1.4-MDa complex built around a DYNC1H1 homodimer. The human core contains two intermediate chains, two light-intermediate chains and six light-chain copies; these non-catalytic chains stabilize the complex, regulate activity and help recruit cargo and cofactors. | Wong et al., 2024, 10.1083/jcb.202306048 (wong2024genomescalerequirementsfor pages 1-2); Dahl et al., 2021, 10.1371/journal.pone.0248354 (dahl2021effectofconditional pages 1-2) |
| Direction and cellular location | Established: The motor acts in the cytoplasm on microtubules, moving predominantly toward microtubule minus ends—usually inward toward centrosomal/perinuclear regions and, in axons, retrogradely toward the neuronal soma. It is not an axonemal beating motor and does not perform dynein-2-dependent retrograde intraflagellar transport. | Rao & Gennerich, 2024, 10.3390/cells13040330 (rao2024structureandfunction pages 1-2); Wong et al., 2024, 10.1083/jcb.202306048 (wong2024genomescalerequirementsfor pages 1-2) |
| Cargo specificity | Established: DYNC1H1 itself supplies the conserved motor, whereas accessory chains and activating adaptors confer cargo specificity. Documented cargo classes include endosomes, lysosomes, phagosomes, autophagic compartments, mitochondria, Golgi-derived and other membrane vesicles, nuclei, macromolecular/RNP assemblies and some intracellular pathogens. RUFY-family adaptors connect dynein to Rab14-positive endosomes and lysosomal-positioning pathways. | Park et al., 2024, 10.1038/s12276-024-01200-7 (park2024cargospecificityregulation pages 5-6); Dahl et al., 2021, 10.1371/journal.pone.0248354 (dahl2021effectofconditional pages 1-2) |
| Activation by dynactin and adaptors | Established: Free mammalian dynein can occupy an autoinhibited “phi” conformation. Dynactin plus a cargo-selective activating adaptor stabilizes an open, processive dynein assembly. Adaptors such as BICD proteins, HOOK proteins, JIP3 and RUFY proteins both recruit cargo and regulate motor number, velocity and force production. | Canty & Yildiz, 2020, 10.1016/j.tibs.2020.02.002 (canty2020activationandregulation pages 9-11); Park et al., 2024, 10.1038/s12276-024-01200-7 (park2024cargospecificityregulation pages 5-6) |
| LIS1 mechanism—2024 advance | Established structural mechanism: Cryo-EM of microtubule-bound dynein–dynactin–JIP3 showed an assembly containing one dynactin, two dynein dimers/four motor domains and two LIS1 dimers. LIS1 simultaneously contacts the DYNC1H1 motor and dynactin p150, stabilizes a pre-powerstroke motor state and helps prime productive adaptor binding; DIC-N first opens autoinhibited p150. JIP3’s RH1/LZI region is sufficient for activation, while an internal helix mediates JIP3 autoinhibition. | Singh et al., Science, March 2024, 10.1126/science.adk8544 (singh2024molecularmechanismof pages 3-4, singh2024molecularmechanismof pages 8-9, singh2024molecularmechanismof pages 6-8) |
| Biological processes | Established: Dynein-1 supports endolysosomal and autophagic trafficking, organelle positioning, Golgi organization, neuronal retrograde axonal transport and signaling-endosome movement, nuclear positioning and migration, and spindle/chromosome functions during cell division. Conditional Dync1h1 deletion in mouse photoreceptors caused rapid degeneration within two postnatal weeks and disrupted retinal lamination, nuclear positioning, membrane-protein trafficking and inner/outer-segment development. | Dahl et al., 2021, 10.1371/journal.pone.0248354 (dahl2021effectofconditional pages 1-2); Canty & Yildiz, 2020, 10.1016/j.tibs.2020.02.002 (canty2020activationandregulation pages 9-11) |
| Systems-level regulation—2024 advance | Emerging resource: A genome-wide arrayed CRISPR loss-of-function screen in human cells used dynein-tethered peroxisomes and early endosomes as readouts and recovered 195 validated hits, separating general from cargo-selective regulators. Follow-up implicated the RNA-binding protein SUGP1 in maintaining functional LIS1 expression. This expands the candidate regulatory network but does not make every hit a validated direct DYNC1H1 interactor. | Wong et al., 2024, 10.1083/jcb.202306048 (wong2024genomescalerequirementsfor pages 1-2) |
| Human disease spectrum | Established genetic association; mechanisms remain variant-dependent: Dominant pathogenic DYNC1H1 variants cause a continuum spanning lower-extremity-predominant spinal muscular atrophy, axonal Charcot–Marie–Tooth disease, intellectual disability, epilepsy and cortical malformations. Tail/dimerization-region variants more often emphasize peripheral neuromuscular disease, whereas motor-domain variants more often involve severe CNS phenotypes, although overlap is substantial. | Becker et al., 2020, 10.1038/s10038-020-0803-1 (simoes2018cytoskeletonandmolecular pages 86-89); Li et al., 2022, 10.3389/fneur.2022.943324 (park2024cargospecificityregulation pages 5-6) |
| Recent clinical statistics | Recent cohort evidence: A study published online 8 June 2024 analyzed 47 affected individuals from 43 families, aged 0–59 years. Sensory neuropathy occurred in 9/47; median onset was 10.6 years, five diagnoses occurred after the second decade and three cases were progressive. The study proposed a lifelong, sometimes biphasic neurodevelopmental–neurodegenerative course. | Möller et al., online 8 June 2024; Brain 2025, 10.1093/brain/awae183 (moller2025theexpandingclinical pages 1-2) |
| Translational and diagnostic status | Current implementation: DYNC1H1 is clinically actionable mainly through molecular diagnosis—multigene panels, exome/genome sequencing, variant interpretation, counseling and phenotype-directed surveillance. No approved DYNC1H1-corrective therapy is established. Modulating dynein/adaptor activity is an experimental therapeutic concept because systemic inhibition risks disrupting an essential ubiquitous motor. | Park et al., 2024, 10.1038/s12276-024-01200-7 (park2024cargospecificityregulation pages 5-6); Möller et al., online 2024, 10.1093/brain/awae183 (moller2025theexpandingclinical pages 1-2) |
| Non-genetic therapeutic exploration | Preclinical, not DYNC1H1-specific treatment: Hyperglycemia activated an AMPK–SP1 program that increased Dync1h1 and other dynein-component expression in podocytes; SP1 inhibition with mithramycin reduced dynein-associated mistrafficking and protected streptozotocin-treated mice from podocytopathy and nephropathy. This supports pathway modulation in diabetic kidney disease but does not establish efficacy or safety in humans or in inherited DYNC1H1 disorders. | Williquett et al., published online 12 March 2024, 10.34067/KID.0000000000000392 (williquett2024ampksp1–guideddyneinexpression pages 1-2) |
Table: Compact evidence matrix distinguishing established molecular and cellular functions of human DYNC1H1/Q14204 from emerging disease and preclinical findings. It highlights mechanistic advances and quantitative results reported in 2024.
DYNC1H1 forms a homodimer through its N-terminal tail. The tail provides a scaffold for two intermediate chains, two light-intermediate chains and six light-chain copies. Its C-terminal motor region contains six AAA+ modules arranged as a ring. The heavy chain is approximately 500 kDa, whereas the assembled dynein-1 complex is approximately 1.3–1.4 MDa. (rao2024structureandfunction pages 1-2, wong2024genomescalerequirementsfor pages 1-2, dahl2021effectofconditional pages 1-2)
The six AAA modules are functionally differentiated. AAA1 is the principal ATPase; AAA3 and AAA4 regulate motor behavior; AAA2 binds ATP but has no established catalytic turnover; AAA5 and AAA6 have lost nucleotide-binding activity and function structurally. A linker emerging from AAA1 undergoes nucleotide-dependent docking and undocking and acts as the principal mechanical element. A roughly 13-nm antiparallel coiled-coil stalk extends from AAA4 and terminates in the microtubule-binding domain; an AAA5-derived buttress communicates ring conformational changes to the stalk. Sliding between the stalk helices changes microtubule affinity. (rao2024structureandfunction pages 1-2)
This architecture establishes why the provided domain annotations are coherent: AAA+, AAA_9 and AAA-lid annotations describe the nucleotide-dependent motor ring and its conformational machinery, whereas the DHC annotation identifies the larger dynein-heavy-chain scaffold. It also distinguishes Q14204 from DYNC2H1, which powers retrograde intraflagellar transport, and from axonemal dyneins, which generate ciliary beating. Cytoplasmic dynein-1 instead carries out broad cytoplasmic transport and organization. (rao2024structureandfunction pages 1-2)
The core reaction is ATP hydrolysis, principally at AAA1:
ATP + H₂O → ADP + phosphate + mechanical work.
Nucleotide-state changes rearrange the AAA ring and linker, are transmitted through the buttress and stalk, and alter the affinity of the terminal microtubule-binding domain. Repeated cycles produce force and stepping toward microtubule minus ends. AAA3 and AAA4 modulate this cycle rather than replacing AAA1 as the principal catalytic site. Thus, DYNC1H1’s specificity is best defined as ATP-dependent motility on microtubules, with cargo specificity supplied largely by associated chains and adaptors. (rao2024structureandfunction pages 1-2, dahl2021effectofconditional pages 1-2)
Unactivated mammalian dynein can fold into an autoinhibited “phi” particle. Binding of dynactin plus an activating adaptor opens and aligns the heavy-chain tails, producing sustained processive movement. Adaptors—including BICD-family proteins, HOOK proteins, JIP3 and RUFY-family proteins—combine motor activation with cargo recognition. Dynactin increases processivity and provides an extended scaffold on which one or more dynein dimers can assemble. (park2024cargospecificityregulation pages 5-6, canty2020activationandregulation pages 9-11)
DYNC1H1 operates in the cytoplasm on microtubules. Because many interphase microtubules have minus ends enriched near centrosomes and the microtubule-organizing center, its activity commonly concentrates cargo in juxtanuclear or perinuclear regions. In polarized neurons, it powers long-range retrograde axonal transport from distal processes toward the soma. Its localization is dynamic rather than restricted to one organelle: cargo receptors, dynactin and adaptors recruit the motor to particular membranes or macromolecular assemblies. (wong2024genomescalerequirementsfor pages 1-2)
Major cargo classes include endosomes, lysosomes, phagosomes, autophagic compartments, mitochondria, Golgi-associated vesicles, nuclei, ribonucleoprotein assemblies, signaling endosomes and some intracellular pathogens. RUFY1 links dynein to Rab14-positive recycling/sorting endosomes, whereas RUFY3 and RUFY4 participate in lysosome positioning. The conserved heavy chain supplies force; accessory chains and adaptors explain how one principal dynein-1 motor can service diverse cargoes. (park2024cargospecificityregulation pages 5-6, dahl2021effectofconditional pages 1-2)
Consequently, the best-supported biological pathways are:
Conditional deletion provides direct in-vivo evidence. In mouse photoreceptors, excision that removed the motor and microtubule-binding regions caused rapid degeneration within two postnatal weeks, severe retinal-layer disorganization by postnatal day 6, defective nuclear positioning and membrane-protein trafficking, and impaired inner/outer-segment elaboration. These findings support a causal transport role rather than a purely correlative localization. The study was published 11 March 2021, DOI: https://doi.org/10.1371/journal.pone.0248354. (dahl2021effectofconditional pages 1-2)
The current expert model is that dynein’s activity is determined at the level of higher-order assembly. Dynactin and an activating adaptor convert largely inactive dynein into a processive cargo motor; the adaptor simultaneously selects cargo and influences motor stoichiometry, velocity and force. LIS1 is not merely a passive motor-binding factor: it promotes formation of active dynein–dynactin–adaptor assemblies. (canty2020activationandregulation pages 9-11, singh2024molecularmechanismof pages 1-3)
A major 2024 advance came from Singh and colleagues’ microtubule-bound cryo-EM structures of dynein–dynactin assembled with LIS1 and the lysosomal adaptor JIP3. One resolved assembly contained one dynactin, two dynein dimers—four motor domains—and two LIS1 dimers. The dynein-B motors contacted the microtubule, whereas LIS1-bound dynein-A motors were held in a detached, pre-powerstroke configuration. LIS1 simultaneously contacted the dynein motor and dynactin’s p150 arm, thereby orienting the components for productive adaptor binding. (singh2024molecularmechanismof pages 3-4, singh2024molecularmechanismof pages 6-8)
Mechanistically, the dynein intermediate-chain N-terminus first helps open p150’s autoinhibited CC1A/CC1B hairpin. This exposes p150 for simultaneous contact with LIS1 and the dynein motor. JIP3’s RH1/LZI region then organizes dynein tails on dynactin; an internal JIP3 helix can autoinhibit this interaction. WD40-only LIS1 constructs could bind the motor but could not restore cellular mitochondrial transport or activate processive movement, indicating that bridging to p150 is functionally important. The peer-reviewed Science article appeared in March 2024, DOI: https://doi.org/10.1126/science.adk8544. (singh2024molecularmechanismof pages 37-40, singh2024molecularmechanismof pages 8-9, singh2024molecularmechanismof pages 6-8)
Wong and colleagues conducted a genome-wide arrayed CRISPR loss-of-function screen in human cells, using dynein-tethered peroxisome and early-endosome distributions as imaging readouts. They obtained 195 validated hits, which could be divided into broad dynein regulators and cargo-selective factors. Follow-up implicated the RNA-binding protein SUGP1 in maintaining functional LIS1 expression. This is a hypothesis-generating regulatory map—not proof that all 195 proteins directly interact with DYNC1H1. The article was published in Journal of Cell Biology in 2024, DOI: https://doi.org/10.1083/jcb.202306048. (wong2024genomescalerequirementsfor pages 1-2)
A 2024 synthesis emphasized that dynein-1 has one principal motor isoform despite extraordinary cargo diversity; specificity emerges from activating adaptors, phosphorylation, temperature, microtubule properties and cargo-receptor networks. Newly characterized RUFY and related factors extend dynein recruitment to endosomal and lysosomal pathways. This supports an annotation in which DYNC1H1 is the common force generator rather than a cargo-specific receptor. Park et al. was published in April 2024, DOI: https://doi.org/10.1038/s12276-024-01200-7. (park2024cargospecificityregulation pages 5-6)
Disease-informed motor engineering and optical-trapping work identified a microtubule-binding-domain mutation that selectively impaired dynein under load, producing a spindle/anaphase phenotype while sparing several other dynein-dependent processes. This demonstrates that apparently pleiotropic DYNC1H1 functions can be separated by the mechanical regime under which the motor operates. The preprint appeared in August 2023 and the peer-reviewed study in 2024; preprint DOI: https://doi.org/10.1101/2023.08.03.551815. (salvadorgarcia2023aforcesensitivemutation pages 39-43)
Heterozygous pathogenic DYNC1H1 variants cause a continuum of “dyneinopathies,” including spinal muscular atrophy with lower-extremity predominance, axonal Charcot–Marie–Tooth disease, intellectual disability, epilepsy and cortical-development abnormalities. Genotype–phenotype trends suggest that tail/dimerization-region variants more often emphasize peripheral neuromuscular disease, whereas motor-domain variants more often produce central nervous system malformations or severe neurodevelopmental phenotypes. These are probabilistic trends with substantial overlap, not deterministic rules. (park2024cargospecificityregulation pages 5-6, simoes2018cytoskeletonandmolecular pages 86-89)
The mechanistic basis is variant-specific. Tail mutations may disturb dimerization, accessory-chain assembly or cargo/adaptor recruitment; motor-ring, stalk or microtubule-binding-domain substitutions may alter ATPase coupling, track affinity, stepping or load response. Long axons are particularly vulnerable because they depend on sustained transport over extreme distances, although DYNC1H1 is ubiquitous and disease is not exclusively neuronal. (simoes2018cytoskeletonandmolecular pages 86-89, salvadorgarcia2023aforcesensitivemutation pages 39-43)
A recent international cohort, accepted in May and published online 8 June 2024 before appearing in Brain in 2025, included 47 individuals from 43 families, aged 0–59 years. Sensory neuropathy occurred in 9/47 (19%); median onset was 10.6 years, five affected individuals were diagnosed only after the second decade, and three showed progressive age-dependent sensory neuropathy. The authors described developmental regression in the first decade, relative stability, and later neurodegenerative progression in some patients. Viral illnesses appeared to exacerbate disease in several cases, but this observation does not yet establish a general causal antiviral mechanism. DOI: https://doi.org/10.1093/brain/awae183. (moller2025theexpandingclinical pages 1-2)
The principal real-world application is molecular diagnosis. DYNC1H1 is included in neuromuscular, neuropathy, epilepsy and neurodevelopmental gene panels and in exome/genome analysis. A molecular diagnosis can distinguish DYNC1H1-related lower-extremity-predominant SMA from 5q-SMA, inform counseling, prompt surveillance for CNS, sensory, orthopedic and multisystem manifestations, and prevent inappropriate assumptions that all SMA-like disease is SMN1-related. The broad and overlapping phenotype makes sequence-based diagnosis especially important. (park2024cargospecificityregulation pages 5-6, moller2025theexpandingclinical pages 1-2)
There is currently no established DYNC1H1-corrective therapy. Direct systemic inhibition is intrinsically risky because dynein-1 is ubiquitous and essential. More plausible strategies include variant-selective correction, restoration of defective assembly, cargo/adaptor-specific modulation, or tissue-restricted intervention. These remain investigational. (park2024cargospecificityregulation pages 5-6, wong2024genomescalerequirementsfor pages 1-2)
One preclinical example outside inherited dyneinopathy linked hyperglycemia to AMPK–SP1-dependent upregulation of Dync1h1 and other dynein components in podocytes. Chemical or genetic SP1 inhibition reversed dynein-associated mistrafficking, and mithramycin protected streptozotocin-treated mice from podocytopathy and diabetic-nephropathy progression. This is evidence for pathway modulation in a mouse metabolic-disease model, not a treatment for pathogenic DYNC1H1 variants and not established human efficacy. The study was published online 12 March 2024, DOI: https://doi.org/10.34067/KID.0000000000000392. (williquett2024ampksp1–guideddyneinexpression pages 1-2)
The highest-confidence annotation is: DYNC1H1/Q14204 is the catalytic heavy chain of human cytoplasmic dynein-1, an ATP-dependent microtubule-minus-end motor whose N-terminal tail assembles accessory chains and whose C-terminal AAA+ motor converts ATP hydrolysis into force through linker, stalk and microtubule-binding-domain conformational changes. Dynactin, LIS1 and cargo-selective activating adaptors regulate processivity and connect the motor to endosomal, lysosomal, autophagic, neuronal, mitotic and organelle-positioning pathways.
Structural and reconstitution evidence strongly supports the mechanochemical and activation model. Conditional deletion and genome editing support essential cellular and tissue functions. Human genetics establishes disease relevance, but individual pathogenic mechanisms and therapeutic tractability remain incompletely resolved. The most important 2024 conceptual shift is that LIS1, p150, intermediate chain and activating adaptors form an ordered assembly pathway that determines when and where DYNC1H1 becomes a processive cargo motor. (singh2024molecularmechanismof pages 3-4, singh2024molecularmechanismof pages 6-8, rao2024structureandfunction pages 1-2, wong2024genomescalerequirementsfor pages 1-2)
References
(rao2024structureandfunction pages 1-2): Lu Rao and Arne Gennerich. Structure and function of dynein’s non-catalytic subunits. Cells, 13:330, Feb 2024. URL: https://doi.org/10.3390/cells13040330, doi:10.3390/cells13040330. This article has 15 citations.
(wong2024genomescalerequirementsfor pages 1-2): Chun Hao Wong, Steven W. Wingett, Chen Qian, Morag Rose Hunter, J. Matthew Taliaferro, Douglas Ross-Thriepland, and Simon L. Bullock. Genome-scale requirements for dynein-based transport revealed by a high-content arrayed crispr screen. The Journal of Cell Biology, Mar 2024. URL: https://doi.org/10.1083/jcb.202306048, doi:10.1083/jcb.202306048. This article has 7 citations.
(dahl2021effectofconditional pages 1-2): Tiffanie M. Dahl, Michelle Reed, Cecilia D. Gerstner, Guoxin Ying, and Wolfgang Baehr. Effect of conditional deletion of cytoplasmic dynein heavy chain dync1h1 on postnatal photoreceptors. PLoS ONE, 16:e0248354, Mar 2021. URL: https://doi.org/10.1371/journal.pone.0248354, doi:10.1371/journal.pone.0248354. This article has 22 citations and is from a peer-reviewed journal.
(simoes2018cytoskeletonandmolecular pages 86-89): FAAL Simoes. Cytoskeleton and molecular motors in the causation of motor neuron diseases. Unknown journal, 2018.
(park2024cargospecificityregulation pages 5-6): Jin-Gyeong Park, Hanul Jeon, Kwang Yeon Hwang, Sun-Shin Cha, Rafael T. Han, Hyesung Cho, and In-Gyun Lee. Cargo specificity, regulation, and therapeutic potential of cytoplasmic dynein. Experimental & Molecular Medicine, 56:827-835, Apr 2024. URL: https://doi.org/10.1038/s12276-024-01200-7, doi:10.1038/s12276-024-01200-7. This article has 10 citations and is from a peer-reviewed journal.
(canty2020activationandregulation pages 9-11): John T. Canty and Ahmet Yildiz. Activation and regulation of cytoplasmic dynein. Trends in biochemical sciences, 45 5:440-453, May 2020. URL: https://doi.org/10.1016/j.tibs.2020.02.002, doi:10.1016/j.tibs.2020.02.002. This article has 111 citations and is from a domain leading peer-reviewed journal.
(singh2024molecularmechanismof pages 3-4): Kashish Singh, Clinton K. Lau, Giulia Manigrasso, José B. Gama, Reto Gassmann, and Andrew P. Carter. Molecular mechanism of dynein-dynactin complex assembly by lis1. Mar 2024. URL: https://doi.org/10.1126/science.adk8544, doi:10.1126/science.adk8544. This article has 93 citations and is from a highest quality peer-reviewed journal.
(singh2024molecularmechanismof pages 8-9): Kashish Singh, Clinton K. Lau, Giulia Manigrasso, José B. Gama, Reto Gassmann, and Andrew P. Carter. Molecular mechanism of dynein-dynactin complex assembly by lis1. Mar 2024. URL: https://doi.org/10.1126/science.adk8544, doi:10.1126/science.adk8544. This article has 93 citations and is from a highest quality peer-reviewed journal.
(singh2024molecularmechanismof pages 6-8): Kashish Singh, Clinton K. Lau, Giulia Manigrasso, José B. Gama, Reto Gassmann, and Andrew P. Carter. Molecular mechanism of dynein-dynactin complex assembly by lis1. Mar 2024. URL: https://doi.org/10.1126/science.adk8544, doi:10.1126/science.adk8544. This article has 93 citations and is from a highest quality peer-reviewed journal.
(moller2025theexpandingclinical pages 1-2): Birk Möller, Lena-Luise Becker, Afshin Saffari, Alexandra Afenjar, Emanuele G Coci, Rachel Williamson, Catherine Ward-Melver, Marc Gibaud, Lucie Sedláčková, Petra Laššuthová, Zuzana Libá, Markéta Vlčková, Nancy William, Eric W Klee, Ralitza H Gavrilova, Jonathan Lévy, Yline Capri, Mena Scavina, Robert Walter Körner, Zaheer Valivullah, Claudia Weiß, Greta Marit Möller, Zoë Frazier, Amy Roberts, Blanca Gener, Marcello Scala, Pasquale Striano, Federico Zara, Moritz Thiel, Margje Sinnema, Erik-Jan Kamsteeg, Sandra Donkervoort, Veronique Duboc, Khaoula Zaafrane-Khachnaoui, Nour Elkhateeb, Laila Selim, Henri Margot, Victor Marin, Claire Beneteau, Bertrand Isidor, Benjamin Cogne, Boris Keren, Benno Küsters, Alan H Beggs, Abigail Sveden, Maya Chopra, Casie A Genetti, Joost Nicolai, Jörg Dötsch, Anne Koy, Carsten G Bönnemann, Maja von der Hagen, Jürgen-Christoph von Kleist-Retzow, Nicol C Voermans, Heinz Jungbluth, and Hormos Salimi Dafsari. The expanding clinical and genetic spectrum of dync1h1-related disorders. Brain, 148:597-612, Jun 2025. URL: https://doi.org/10.1093/brain/awae183, doi:10.1093/brain/awae183. This article has 30 citations and is from a highest quality peer-reviewed journal.
(williquett2024ampksp1–guideddyneinexpression pages 1-2): Jillian Williquett, Chantal Allamargot, and Hua Sun. Ampk-sp1–guided dynein expression represents a new energy-responsive mechanism and therapeutic target for diabetic nephropathy. Kidney360, 5:538-549, Mar 2024. URL: https://doi.org/10.34067/kid.0000000000000392, doi:10.34067/kid.0000000000000392. This article has 2 citations and is from a peer-reviewed journal.
(salvadorgarcia2023aforcesensitivemutation pages 39-43): David Salvador-Garcia, Li Jin, Andrew Hensley, Mert Gölcük, Emmanuel Gallaud, Sami Chaaban, Fillip Port, Alessio Vagnoni, Vicente José Planelles-Herrero, Mark A. McClintock, Emmanuel Derivery, Andrew P. Carter, Régis Giet, Mert Gür, Ahmet Yildiz, and Simon L. Bullock. A force-sensitive mutation reveals a spindle assembly checkpoint-independent role for dynein in anaphase progression. bioRxiv, Aug 2023. URL: https://doi.org/10.1101/2023.08.03.551815, doi:10.1101/2023.08.03.551815. This article has 2 citations.
(singh2024molecularmechanismof pages 1-3): Kashish Singh, Clinton K. Lau, Giulia Manigrasso, José B. Gama, Reto Gassmann, and Andrew P. Carter. Molecular mechanism of dynein-dynactin complex assembly by lis1. Mar 2024. URL: https://doi.org/10.1126/science.adk8544, doi:10.1126/science.adk8544. This article has 93 citations and is from a highest quality peer-reviewed journal.
(singh2024molecularmechanismof pages 37-40): Kashish Singh, Clinton K. Lau, Giulia Manigrasso, José B. Gama, Reto Gassmann, and Andrew P. Carter. Molecular mechanism of dynein-dynactin complex assembly by lis1. Mar 2024. URL: https://doi.org/10.1126/science.adk8544, doi:10.1126/science.adk8544. This article has 93 citations and is from a highest quality peer-reviewed journal.